Evotec Se (EVO) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Evotec Se  (NASDAQ: EVO)


Evotec Se's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Evotec Se's ROI in the fourth quarter of 2025?
Evotec Se recorded a cumulative net loss of $-116 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -7.14%.

Within the Healthcare sector 319 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 0 to 3364.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM 48.34 % 30.13 % 13.95 % -1.03 % -14.95 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,623 1,623 1,623 1,623 1,110
Return On Investment (TTM) -7.14 % -14.69 % -16.13 % -17.89 % -20.07 %
EVO's Overall Ranking # 3364 # 0 # # #
Seq. Investment Change TTM 8.58 % 9.81 % 10.88 % 12.21 % -4.75 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -116 -220 -220 -220 -220

EVO Company Profile >> Back to EVO Roi Comparisons >> See Annual EVO Return On Investment



Return On Investment EVO's Ranking
Within: No.
Industry # 118
Sector # 320
Overall # 3364

Return On Investment Statistics
High Average Low
11.53 %
-8.61 %
-20.17 %
(Dec 31 2021)   (Dec 31 2024)







Financial Statements
Evotec Se's IV. Quarter Investments $ 1,623 Millions EVO's Balance sheet
Evotec Se's IV. Quarter Income $ -116 Millions Quarterly EVO's Income Statement
EVO's Income by Division See EVO's Income by Division


EVO Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 932 1,110 1,328 1,361 2,177
Y / Y Investment Growth -16.08 % -16.44 % -2.36 % -37.49 % -
Net Income in Millions -116 -212 -91 -185 255
Y / Y Net Income Growth - - - - -
Annual Return On Investment -12.45 % -19.11 % -6.83 % -13.6 % 11.71 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EVO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EVO's Competitors
Subscribers only: Roi for Evotec Se's Suppliers
Subscribers only: Return On Investment for EVO's Customers

Other Ratios
EVO's Roa EVO's Inventory Turnover Ratio EVO's Growth Rates EVO's Dividend Statistics
EVO's Profitability Ratios EVO's Asset Turnover Ratio EVO's Dividend Growth
EVO's Roe EVO's Valuation Ratios EVO's Financial Strength Ratios EVO's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI

Date modified: 2026-07-07T10:39:15+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.